S Tag Peptide (A6007): Practical Guide for Fusion Tag Workfl
2026-07-24
The S Tag Peptide provides a highly soluble, antibody-compatible fusion tag for efficient recombinant protein detection, purification, and solubility improvement. It is best applied in aqueous workflows with anti-S-Tag antibody detection but should not be used in ethanol-based protocols or where the tag's independent enzymatic activity is required.
Ganetespib (STA-9090) in Applied Cancer Research Workflows
2026-07-23
Ganetespib (STA-9090) redefines Hsp90 inhibition with high potency and selectivity, streamlining preclinical cancer models. This article delivers actionable protocols, optimization strategies, and troubleshooting insights for maximizing experimental performance in tumor growth inhibition and chaperone disruption assays.
Targeting NUAK1-Mediated Tau Phosphorylation in Alzheimer's
2026-07-23
This study delineates the pathological relevance of tau phosphorylation at Ser356 in Alzheimer’s disease and demonstrates that NUAK1/2 inhibition with WZ4003 reduces p-tau Ser356 levels in brain slice cultures. The findings suggest a mechanistically distinct route to modulate tau pathology, with implications for translational models of neurodegeneration.
Palmitic acid (Hexadecanoic Acid): Technical Protocol Guidan
2026-07-22
Palmitic acid (hexadecanoic acid, SKU N2456) is a high-purity saturated long-chain fatty acid for targeted in vitro research on lipid metabolism, protein palmitoylation, and metabolic disorder pathways. It should not be used in protocols requiring aqueous solubility or long-term solution stability, making careful preparation and handling critical for reproducible results.
Topotecan and Carboplatin Regimens in Ovarian Cancer: System
2026-07-22
This Cochrane review rigorously evaluates the clinical benefit and toxicity profiles of adding topotecan to standard carboplatin/paclitaxel regimens in ovarian cancer. The findings clarify the impact on survival and progression, informing preclinical and translational study design.
Patient-Derived Gastric Cancer Assembloids Advance Drug Test
2026-07-21
This study introduces a patient-derived gastric cancer assembloid model integrating matched tumor organoids and stromal cells, providing a physiologically relevant system for drug response analysis. The model uncovers critical roles for stromal components in modulating gene expression and therapy resistance, enhancing precision in preclinical cancer research.
E-64: Precision Cysteine Protease Inhibition for Research
2026-07-21
E-64, a potent L-trans-epoxysuccinyl peptide, sets the standard for irreversible cysteine protease inhibition in mechanistic, cancer, and cell biology research. This article unpacks practical workflows, key reference advances, and troubleshooting insights to empower reproducible results across diverse experimental models.
Angiotensin II–HIF-1α-HILPDA Axis Drives Radioresistance in
2026-07-20
This study uncovers how local angiotensin II sustains radioresistance in nasopharyngeal carcinoma (NPC) by suppressing ferroptosis through the HIF-1α-HILPDA axis. The mechanistic insights highlight AGT, HIF-1α, and HILPDA as biomarkers and therapeutic targets to enhance radiosensitivity in NPC.
Antibacterial Use and Resistance in Psychiatric Hospitals Du
2026-07-20
A recent study provides the first detailed, quantitative analysis of antibacterial drug use and bacterial resistance patterns in a psychiatric hospital during the COVID-19 epidemic. The findings highlight relatively low antibiotic consumption but a concerning rise in resistance, underscoring the need for ongoing surveillance and evidence-based antimicrobial stewardship.
Advancing Bioluminescent Assays with EZ Cap™ Firefly Lucifer
2026-07-19
Uncover how Firefly Luciferase mRNA with 5-moUTP modification elevates mRNA delivery and reporting, leveraging LNP innovations for robust, immune-silent gene expression studies. This article provides deep technical insight and unique comparative analysis.
FPR2/ALX Stimulation Limits Neuroinflammation via Microglia
2026-07-18
The reference study demonstrates that stimulating FPR2/ALX with Quin-C1 in a mouse model of autoimmune astrocytopathy reduces neuroinflammation and demyelination by modulating microglia and natural killer (NK) cell activity. These findings clarify the underlying SYK-AKT pathway and highlight FPR2/ALX as a promising target for treating diseases such as neuromyelitis optica spectrum disorder (NMOSD).
NMDA (N-Methyl-D-aspartic acid) in Excitotoxicity & Neurodeg
2026-07-17
NMDA (N-Methyl-D-aspartic acid) from APExBIO is a benchmark tool for modeling excitotoxicity and neurodegenerative mechanisms in vitro and in vivo. Its validated use in glaucoma models and oxidative stress assays enables reproducible insights into neuronal cell death and protection strategies.
Palmitic acid (Hexadecanoic Acid): Technical Parameters & Us
2026-07-17
Palmitic acid (SKU N2456) addresses the need for a high-purity, well-characterized saturated long-chain fatty acid suitable for research on lipid metabolism, metabolic disorder pathways, and protein palmitoylation. It is not appropriate for workflows requiring aqueous solubility or long-term solution storage, and precise handling is essential to ensure reproducibility.
HDAC Inhibitors Suppress NUT Function in NUT Carcinoma Cells
2026-07-16
Shiota et al. conducted a high-throughput chemical screen that revealed diverse histone deacetylase (HDAC) inhibitors as potent repressors of NUT-mediated transcriptional activity in NUT carcinoma. This work highlights the mechanistic role of HDAC inhibition in disrupting oncogenic chromatin megadomains, offering new insights into epigenetic vulnerabilities and treatment strategies for this aggressive cancer.
YAP-TEAD–Super-Enhancer Regulation in Surface Ectoderm Fate
2026-07-16
Wang et al. reveal how the YAP-TEAD transcriptional complex orchestrates a super-enhancer (SE) network to drive early surface ectoderm commitment from pluripotent stem cells. Their integrative chromatin mapping and functional genomics uncover a new mechanistic axis for regulating epithelial lineage specification, informing future regenerative and stem cell-based strategies.
507 records 14/34 page Previous Next First page 上5页 1112131415 下5页 Last page